Figures computed from official regulatory filings — .
Ownershipinsiders 0% · institutions 0% · short 6.2% of float
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for BIMI Holdings Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical solution, and pharmaceutical and other healthcare products in the People's Republic of China and the United States. The company operates through four segments: Medical Devices; Healthcare Products; Wholesale Pharmaceuticals; and Pharmacy Retail. The Pharmacy Retail segment offers prescription and OTC medicines; TCM; healthcare supplies; traditional Chinese medicines; and sundry items. The Wholesale Pharmaceuticals segment provides prescription; OTC medicines; TCM; healthcare supplies; and sundry items. The Medical Device segment distributes medical devices, including medical consumables. The Healthcare products segment offers dietary supplements comprising cardiovascular products; anti-insomnia and depression products; male aphrodisiac products; menopausal syndrome products; gout products; and immunity products. It sells its products through pharmacies; retail stores; private and government clinics; directly owned stores; third party pharmacies; hospitals; drug wholesalers; and medical device dealers. The company was formerly known as BIMI International Medical Inc. and changed its name to BIMI Holdings Inc. in January 2024. The company was incorporated in 2000 and is based in New York, New York.
Market information source · Oct 19, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 19, 2026
Open-market timeline · full history
2 buys10 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| LIHUA WANG | Sell | $288K | SEC | ||
| GANG LI |
| Sell |
| $1.1M |
| SEC |
| LIHUA WANG | Other | $343.7K | SEC |
| GANG LI | Other | $1.4M | SEC |
| MacLean John Coleman | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Jin Lesley | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Yan Jiuding | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Wang Zhongmin | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Ching Mia Kuang | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Wang Jianxin | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| LIHUA WANG | Sell | $7.1B | SEC |
| GANG LI | Sell | $113.2B | SEC |
| LIAONING NENGFA WEIYE NEW ENERGY APPLICATION CO LTD | Sell | $176.9B | SEC |
| LIHUA WANG | Sell | $271B | SEC |
| GANG LI | Sell | $4.3T | SEC |
| LIAONING NENGFA WEIYE NEW ENERGY APPLICATION CO LTD | Sell | $6.8T | SEC |
| GANG LI | Buy | $22.3T | conv 74First in 12mo | SEC |
| GANG LI | Sell | $24.7T | SEC |
| LIHUA WANG | Buy | $1.4T | conv 38First in 12mo | SEC |
| LIHUA WANG | Sell | $677.4B | SEC |